The Journal of Practical Medicine >
Risk factors of supplementary injection after foam sclerotherapy for varicose veins of lower extremities and its impact on blood coagulation function
Received date: 2023-08-15
Online published: 2024-03-08
Objective To explore the risk factors of supplementary injection after foam sclerotherapy for varicose veins of lower extremities and its impact on blood coagulation function. Methods A total of 185 patients with varicose veins of lower limbs diagnosed in the First People′s Hospital of Zunyi from January 2018 to December 2021 were selected. The corresponding pathological data were collected， and the D-dimer， thrombin time， and fibrinogen level of patients were detected 1 d before and 1 d after the surgery. The postoperative video phone follow-up lasted until 6 months after the surgery. The patients were divided into single treatment group and supplementary treatment group according to whether supplementary injection of foam sclerosing agent was needed during the follow-up. Propensity matching on the data between the two groups was conducted， and the correlation between disease course data， coagulation factors， and the occurrence of supplementary injection was analyzed. A time series model for the incidence of supplementary injection was established， and the therapeutic effect and complications were observed. Results After propensity matching， there was still significant difference in the degree of lesion between the two groups （P < 0.05）. On the first day after surgery， there was significant difference in the D-dimer and fibrinogen groups between the two groups （P < 0.05）， and but no significant difference in thrombin time （P > 0.05）. The occurrence of supplementary injection was significantly correlated with D-dimer， fibrinogen， thrombin time， and first-time injection dose （P < 0.05）， and the incidence of supplementary injection was higher in patients who received first-time injection in January， August， September， and December. Both groups achieved successful treatment 6 months after surgery， and there was no significant difference in the incidence of complications. Conclusion Patients with lower limb varicose veins of C3/C4 are more likely to require supplementary injection compared to patients with other levels. The level of D-dimer and fibrinogen at 1 d after surgery is positively correlated with the occurrence of supplementary injection， while the dose of the first injection is negatively correlated with the occurrence of supplementary injection.
Yiping ZHU , Tao XU , Mingmei TANG , Die YANG , Yiman XIE , Xin. TAN . Risk factors of supplementary injection after foam sclerotherapy for varicose veins of lower extremities and its impact on blood coagulation function[J]. The Journal of Practical Medicine, 2024 , 40(4) : 521 -525 . DOI: 10.3969/j.issn.1006-5725.2024.04.014
| 1 | ZHANG J， WU Z， FENG Q，et al.Cardiac Doppler Parameters and Progress in Clinical Manifestation of Primary Lower Extremity Varicose Veins： A Prospective Study in China［J］.Front Surg， 2022， 9：791598. doi:10.3389/fsurg.2022.791598 |
| 2 | RAETZ J， WILSON M， COLLINS K. Varicose Veins： Diagnosis and Treatment［J］. Am Fam Physician， 2019，99（11）： 682-688. |
| 3 | LI N， LI J， HUANG M， et al. Efficacy and safety of polidocanol in the treatment of varicose veins of lower extremities： A protocol for systematic review and meta-analysis［J］. Medicine （Baltimore）， 2021，100（8）： e24500. doi:10.1097/md.0000000000024500 |
| 4 | 万正东， 王玖言， 宋斌， 等. 医用弹力袜辅助器的设计及其在下肢静脉曲张术后的应用［J］. 实用医学杂志， 2016，32（9）： 1548-1549. doi:10.3969/j.issn.1006-5725.2016.09.058 |
| 5 | WANG J C， LI Y， LI G Y， et al. A Comparison of Concomitant Tributary Laser Ablation and Foam Sclerotherapy in Patients Undergoing Truncal Endovenous Laser Ablation for Lower Limb Varicose Veins［J］. J Vasc Interv Radiol， 2018，29（6）： 781-789. doi:10.1016/j.jvir.2018.01.774 |
| 6 | FARAH M H， NAYFEH T， URTECHO M， et al. A systematic review supporting the Society for Vascular Surgery， the American Venous Forum， and the American Vein and Lymphatic Society guidelines on the management of varicose veins［J］. J Vasc Surg Venous Lymphat Disord， 2022，10（5）： 1155-1171. doi:10.1016/j.jvsv.2021.08.011 |
| 7 | KANBER E M. Comparison of Foam and Liquid Sclerotherapy for the Treatment of Lower Extremity Varicose Veins and Telangiectasia in Obese Patients［J］. Cureus， 2023， 15（7）： e42571. |
| 8 | 段成.下肢静脉曲张诊断和微创治疗的临床研究进展［D］.重庆：重庆医科大学，2021. |
| 9 | 中国微循环学会周围血管疾病专业委员会. 聚桂醇注射液治疗下肢静脉曲张微循环专家共识［J］. 血管与腔内血管外科杂志， 2020，6（5）： 377-381. |
| 10 | JOYCE D P， de FREITAS S， WOO E Y， et al. Ultrasound-guided foam sclerotherapy as a therapeutic modality in venous ulceration［J］. Surg， 2022， 20（5）： e206-e213. doi:10.1016/j.surge.2021.08.008 |
| 11 | GOHEL M S， HEATLEY F， LIU X， et al. A randomized trial of early endovenous ablation in venous ulceration［J］. N Engl J Med， 2018， 378（22）： 2105-2114. doi:10.1056/nejmoa1801214 |
| 12 | NAKANO L C， CACIONE D G， BAPTISTA-SILVA J C， et al. Treatment for telangiectasias and reticular veins［J］. Cochrane Database Syst Rev， 2021，10（10）： D12723. doi:10.1002/14651858.cd012723.pub2 |
| 13 | de AVILA O R， RIERA R， VASCONCELOS V， et al. Injection sclerotherapy for varicose veins［J］. Cochrane Database Syst Rev， 2021，12（12）： D1732. doi:10.1002/14651858.cd001732.pub3 |
| 14 | GOSHCHYNSKY V， SVIDERSKY Y， MIGENKO B， et al. Radiofrequency ablation of varicose veins in combination with ultrasonic-assisted wound debridement and platelet-rich plasma as well as platelet-rich fibrin technologies in treatment of lower extremity venous ulcers in office-based surgery［J］. Pan Afr Med J， 2022， 42： 154. |
| 15 | KISHORE R， SANKAR T B， ANANDI A， et al. A Prospective Study in Comparison of Ambulatory Phlebectomy and Duplex Guided Foam Sclerotherapy in the Management of Varicosities with Isolated Perforator Incompetence［J］. Indian J Surg， 2016，78（5）： 356-363. doi:10.1007/s12262-016-1481-2 |
| 16 | 汤辉. 聚桂醇泡沫硬化剂制备及临床应用效果［J］. 粘接， 2021，48（11）： 32-35. doi:10.3969/j.issn.1001-5922.2021.11.009 |
| 17 | 徐明艳，韩校鹏，刘英丽，等. 慢性阻塞性肺疾病急性加重期并发肺动脉高压的危险因素［J］. 实用医学杂志， 2022， 38（19）：2467-2471. |
| 18 | 林岚，刘路浩，张磊，等. D-二聚体在胰肾联合移植术后移植胰血栓形成的预测价值［J］. 实用医学杂志， 2022， 38（16）：2071-2075. doi:10.3969/j.issn.1006-5725.2022.16.017 |
| 19 | 彭贵鑫，管淑红，周军. 内皮特异性分子-1，纤维蛋白原在慢性阻塞性肺疾病急性加重期诊断及病情评估中的价值［J］. 实用医学杂志， 2022， 38（17）：2198-2202. |
| 20 | 叶丝陶，黄晓铨，陈世耀. 血浆纤维蛋白原水平预测乙型肝炎肝硬化患者内镜治疗后食管胃静脉曲张再出血风险效能分析［J］. 实用肝脏病杂志， 2023， 26（3）：392-395. doi:10.3969/j.issn.1672-5069.2023.03.023 |
| 21 | 蒋全，张爱武，朱钰，等. 下肢静脉曲张患者术前检测指标的特点［J］. 血管与腔内血管外科杂志， 2023， 9（3）：363-367. |
| 22 | FALANGA V， GRADA A， OTERO-VINAS M， et al. Autologous Cultured Bone Marrow-Derived Mesenchymal Stem Cells in a Fibrin Spray to Treat Venous Ulcers： A Randomized Controlled Double-Blind Pilot Study［J］. Surg Technol Int， 2022， 40： 47-54. doi:10.52198/22.sti.40.wh1493 |
| 23 | ARASAKUMAR D， PANG C， EVANS N， et al. Efficacy and safety of foam sclerotherapy with sodium tetradecyl sulfate as preferred sclerosant of venous malformations based on experience from a single specialist center［J］. J Vasc Surg Venous Lymphat Disord， 2022， 11（2）：379-388. doi:10.1016/j.jvsv.2022.10.008 |
| 24 | 史春雷， 郭海涛， 姚雪峰， 等. 泡沫硬化术联合激光闭合术治疗大隐静脉曲张的疗效观察［J］. 血管与腔内血管外科杂志， 2022，8（5）： 596-600. |
| 25 | HAMEL-DESNOS C， NYAMEKYE I， CHAUZAT B， et al. FOVELASS： A Randomised Trial of Endovenous Laser Ablation Versus Polidocanol Foam for Small Saphenous Vein Incompetence［J］. Eur J Vasc Endovasc Surg， 2023， 65（3）： 415-423. doi:10.1016/j.ejvs.2022.11.021 |
| 26 | TAYLOR S J， LETHAM B. Forecasting at Scale［J］. The Am statistician， 2018，72（1）： 37-45. doi:10.1080/00031305.2017.1380080 |
/
| 〈 |
|
〉 |